Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This is a single-center, multiple-dose, randomized, double-blind, double-dummy,
placebo-controlled, active-comparator, parallel study in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Reata Pharmaceuticals, Inc.
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination